A total of 60 parturients undergoing induction of labour will be consented to participate in the study where they will be randomized to receive either spinal fentanyl (20 µg) or epidural analgesia (fentanyl 100µg and lidocaine 80 mg). They will be monitored for the development of analgesia for a duration of 30 minutes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
60
Fentanyl citrate 20 µg in 2 ml of saline injected into csf
Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume
Fentanyl citrate 100µg and lidocaine hydrochloride 80 mg in 10 ml volume
HUS/Women's hospital dept of anaesthesia
Helsinki, Finland
Analgesia at 20 minutes
Reduction of visual analog scale (VAS) pain during contraction from pre-intervention value. 0 mm means no pain while 100 mm means worst possible pain.
Time frame: 20 minutes
Time until pain returns to 60 mm VAS
Time from intervention until the maximum pain during contraction return to 60 mm on VAS scale
Time frame: 30-180 minutes
Ambulation during the analgesia provided by the intervention
HAs the parturient been walking during the analgesia provided by the intervention
Time frame: 30-180 minutes
Changes in the cardiotocography (fetal heart rate) within 30 minutes after the intervention
Graded as normal, susceptible, pathological
Time frame: 0-30 minutes
Pruritus
The incidence of pruritus within 30 minutes after the intervention, graded: none, mild, moderate, severe, unbearable
Time frame: 0-30 minutes
SAtisfaction of the parturient with the analgesia provided by the intervention
On 0-100 mm visual analog scale (VAS). Where 0 means no satisfaction at all and 100 mm means maximum satisfaction.
Time frame: at 30 minutes
Cervical dilatation rate cm/h during the analgesia intervention
(The cervical dilatation (1-10 cm) 1-3 hours post analgesia - The cervical dilatation (1-5 cm) before analgesia) / time between measurements (hours)
Time frame: 0-180 min
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Use of oxytocin during the analgesia study period
Oxytocin administered i.v. during 0-30 minutes after the analgesia (yes or no)
Time frame: 30 min